TiGenix to acquire Orthomimetics
TGXSF | Quote | Chart | News | PowerRating -- TiGenix NV has agreed to acquire all the outstanding shares of Orthomimetics, Ltd., a UK-based medical device company. The transaction is valued at approximately EUR16 million on a debt and cash free basis.
TiGenix is a Belgium-based biomedical company focused on treatments for damaged and osteoarthritic joints.
As part of the consideration, TiGenix will issue approximately 3.7 million new shares to Orthomimetics shareholders.
Deal Value (US$ Million) 23.86
Deal Type Acquisition
Sub-Category 100% Acquisition
Deal Status Announced: 2009-11-16
Deal Participants
Target (Company) OrthoMimetics
Acquirer (Company) TiGenix N.V.
Deal Rationale
This transaction will enable TiGenix to strengthen its product portfolio and biomaterials platform and also strengthen its position in the field of regenerative medicine.
For full details on (TGXSF) TGXSF. (TGXSF) has Short Term PowerRatings at TradingMarkets. Details on (TGXSF) Short Term PowerRatings is available at This Link.


